Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors

NCT04896697 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: vilastobart (XTX101)
DRUG: Atezolizumab
DRUG: vilastobart (XTX101)

Sponsor

Xilio Development, Inc.

Collaborators

[object Object]